関連する実験動画
Updated: Sep 10, 2025

16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
26.5K
パーキンソン病に特化した 精神疾患の治療薬が必要でしょうか?
Kelly A Mills1, Gregory M Pontone2,3
1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Journal of Parkinson's disease
|August 21, 2025
まとめ
パーキンソン病 (PD) の患者の精神症状に対する新しい薬の開発には,治療目標へのさらなる注意が必要です. このレビューでは,現在の薬理学的治療法を検討し,改善された治療法の将来の方向性を提案しています.
科学分野:
- 神経科学
- 精神科
- 薬理学について
背景:
- 精神症状はパーキンソン病 (PWP) の患者に多く見られ,しばしば前兆期に現れる.
- これらの症状は,運動障害とその治療法と密接に関連しており, 潜在的メカニズム的なつながりを示唆しています.
研究 の 目的:
- PWPにおける精神症状に対する既存の薬理学的治療法を検討する.
- 精神疾患の症状に対する新しい薬の開発のための将来の戦略と目標を模索する.
主な方法:
- 薬理学的治療のための現在の証拠の文献レビュー.
- 精神症状と運動症状の間の潜在的メカニズム的なリンクの探索.
主要な成果:
- PWPにおける精神症状の現在の薬理学的治療法について論じています.
- 精神症状,運動症状,治療の複雑な相互作用が強調されています.
結論:
- 機械的な関連性に関するさらなる研究が必要である.
- 新しい治療目標とアプローチは パーキンソン病の精神症状に対する効果的な薬の開発に不可欠です
関連する概念動画
Parkinson's Disease: Treatment
377
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
377
Antipsychotic Drugs: Therapeutic Uses and Side Effects
380
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
380
Parkinson's Disease: Overview
703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Psychosis and Antipsychotic Drugs: Overview
454
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
454
Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97

